About Predemtec
We are a company focused on the research, development and manufacturing of innovative diagnostic tests to determine risk factors of dementia-related diseases.
We have set ourselves the goal of being able to diagnose the various forms of dementia earlier and more reliably through the innovative diagnostic tests we have developed. This is because only when detected early can dementia therapy be used effectively and efficiently to delay the manifestation of the disease and mitigate its severity.
Our first test, Predemtec DX, is a serum-based immunoassay for the early and risk diagnosis of senile dementia of the Alzheimer's type.
Note: This article has been translated using a computer system without human intervention. LUMITOS offers these automatic translations to present a wider range of company presentation. Since this article has been translated with automatic translation, it is possible that it contains errors in vocabulary, syntax or grammar. The original article in German can be found here.
Advertisement
